STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

OLPX Form 4: Director Jerome Griffith awarded 110,294 time‑vested RSUs

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Olaplex Holdings insider grant of restricted stock units to a director. Director Jerome Griffith was granted 110,294 restricted stock units (RSUs) of Olaplex common stock on 08/12/2025 at no cash price. Each RSU represents a conditional right to one share and the award will vest in full on the date of the company’s 2026 Annual Meeting of Stockholders, subject to continued service. After the grant, the reporting person beneficially owns 110,294 shares on a direct basis related to these RSUs. The filing states the award was made under the Issuer’s 2021 Equity Incentive Plan.

Positive

  • Alignment with shareholders: RSUs create direct equity exposure for the director, aligning interests with long-term shareholders
  • Retention mechanism: Time-based vesting through the 2026 annual meeting supports director retention without immediate dilution

Negative

  • Potential dilution: 110,294 RSUs will convert to shares upon vesting, increasing outstanding share count when settled
  • No performance conditions disclosed: Vesting is solely time-based rather than tied to performance metrics in this filing

Insights

TL;DR: Director award of 110,294 RSUs ties compensation to future share value; impact is routine but dilutive when settled.

The RSU grant aligns the director’s interests with shareholders by creating upside exposure if the share price rises before vesting. The grant is sizable in absolute terms, but the filing does not provide Olaplex’s outstanding share count, so dilution cannot be quantified here. There is no sale or exercise reported; these are time-based awards contingent on continued service through the 2026 annual meeting. Investors should see this as a standard equity-based compensation action rather than a liquidity event.

TL;DR: Time-vested RSUs for a director reflect standard governance practice to retain and align leadership; disclosure is routine.

The award was granted under the company’s 2021 Equity Incentive Plan and vests only upon continued service, which is a common retention mechanism. The filing transparently discloses the award type, amount, vesting condition, and direct beneficial ownership post-grant. There is no indication of accelerated vesting triggers or related-party conflicts in this filing alone.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Griffith Jerome

(Last) (First) (Middle)
C/O OLAPLEX HOLDINGS, INC.
432 PARK AVENUE SOUTH, THIRD FLOOR

(Street)
NEW YORK NY 10016

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
OLAPLEX HOLDINGS, INC. [ OLPX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
08/12/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/12/2025 A 110,294(1) A $0 110,294 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents restricted stock units ("RSUs") granted to the Reporting Person under the Issuer's 2021 Equity Incentive Plan. Each RSU represents the conditional right to receive one share of Common Stock. The RSUs will vest in full on the date of the Issuer's 2026 Annual Meeting of Stockholders, subject to the Reporting Person's continued service to the Issuer through such vesting date.
Remarks:
/s/ John Duffy, attorney-in-fact 08/14/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Olaplex director Jerome Griffith receive according to the Form 4?

He was granted 110,294 restricted stock units (RSUs), each representing the right to one share of common stock.

When do Jerome Griffith's RSUs vest?

The RSUs vest in full on the date of Olaplex's 2026 Annual Meeting of Stockholders, subject to continued service.

Were any shares sold or exercised in this transaction for OLPX?

No. The Form 4 reports an RSU grant (acquisition) at $0; there were no sales or exercises reported.

Under what plan were the RSUs granted?

The awards were granted under the Issuer's 2021 Equity Incentive Plan as stated in the filing.

Does the Form 4 indicate indirect ownership or related-party arrangements?

No. The filing lists the ownership form as direct and does not disclose any indirect beneficial ownership or special arrangements.
Olaplex Holdings, Inc.

NASDAQ:OLPX

OLPX Rankings

OLPX Latest News

OLPX Latest SEC Filings

OLPX Stock Data

907.82M
138.87M
0.72%
98.17%
1.59%
Specialty Retail
Perfumes, Cosmetics & Other Toilet Preparations
Link
United States
NEW YORK